A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

ClinicalTrials.gov ID: NCT07775924

Public ClinicalTrials.gov record NCT07775924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 17, 2026, 4:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-range Study to Assess the Efficacy and Safety of GIA632 in Participants With Moderate to Severe Cutaneous Lichen Planus, Followed by an Extension Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).

Study identification

NCT ID: NCT07775924
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 259 participants

Conditions and interventions

Conditions

Cutaneous Lichen Planus

Interventions

Placebo Drug
GIA632 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 99 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 29, 2026 (Actual)
Primary completion: Nov 22, 2028 (Estimated)
Completion: Feb 13, 2030 (Estimated)
Last update posted: Oct 13, 2026

2026 – 2030

United States locations

U.S. sites: 15
U.S. states: 10
U.S. cities: 15

Facility	City	State	ZIP	Site status
Cahaba Derm and skin hlth ctr 27	Birmingham	Alabama	35244	Recruiting
First OC Dermatology	Fountain Valley	California	92708	Recruiting
Miami Derm and Laser Institute	Miami	Florida	33173	Recruiting
Global Clinical Professionals	St. Petersburg	Florida	33714	Recruiting
Skin Care Physicians Of Georgia	Macon	Georgia	31217	Recruiting
Dawes Fretzin Clinical Rea Group	Indianapolis	Indiana	46256	Recruiting
Essential Medical Research	Overland Park	Kansas	66213	Recruiting
Louisiana Dermatology Associates	Baton Rouge	Louisiana	70809	Recruiting
Delricht Research	New Orleans	Louisiana	70115	Recruiting
Uni Of Michigan Health System	Ann Arbor	Michigan	48109	Recruiting
Hamzavi Dermatology	Fort Gratiot	Michigan	48059	Recruiting
Skin Specialists PC	Omaha	Nebraska	68144	Recruiting
NextGen Clinical Research and Innovation Inc-Network	Mansfield	Texas	76063	Recruiting
Austin Inst for Clinical Research	Pflugerville	Texas	78660	Recruiting
RFSA Dermatology	San Antonio	Texas	78213	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07775924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07775924 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →